adult giant cell glioblastoma
Showing 9976 - 10000 of >10,000
Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, DLBCL Trial in Kampala (Rituximab and Hyaluronidase Human,
Recruiting
- Burkitt Lymphoma
- +2 more
- Rituximab and Hyaluronidase Human
- +8 more
-
Kampala, UgandaUCI-Fred Hutch Cancer Centre
Mar 9, 2022
Baylor Infant and Toddler Biomarker of Nutrition Study
Not yet recruiting
- Healthy Nutrition
- Healthy Diet
- Carotenoid Intake
- Serum carotenoid concentrations
-
Houston, TexasUSDA/ARS Children's Nutrition Research Center, Baylor College of
May 12, 2023
Bacterial Vaginosis Trial in Sweden (pHyph)
Not yet recruiting
- Bacterial Vaginosis
- pHyph
-
Linköping, Sweden
- +3 more
Nov 7, 2023
Head Neck Cancer, Locally Advanced Trial in Bangkok (Palbociclib, Cetuximab, Intensity Modulated Radiation Therapy)
Active, not recruiting
- Head and Neck Cancer
- Locally Advanced
- Palbociclib
- +2 more
-
Bangkok, ThailandFaculty of Medicine, Ramathibodi Hospital
Sep 19, 2022
Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease Trial in Bruxelles (Clonidine)
Recruiting
- Sickle Cell Disease
- Vaso-occlusive Pain Episode in Sickle Cell Disease
-
Bruxelles, BelgiumCHU Saint-Pierre
May 5, 2023
Smoking, Tobacco Trial in Tulsa (Physician Sent Outreach with Embedded Asynchronous Care in Portal Message, Physician Sent
Completed
- Smoking, Tobacco
- Physician Sent Outreach with Embedded Asynchronous Care in Portal Message
- +3 more
-
Tulsa, OklahomaOklahoma State University Center for Health Sciences
Dec 28, 2021
Depression Trial in Hanoi (Supported Self-Management, Enhanced treatment as usual)
Completed
- Depression
- Supported Self-Management
- Enhanced treatment as usual
-
Hanoi, VietnamInstitute of Population, Health and Development
May 26, 2022
HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,
Recruiting
- HIV Infection
- +10 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
La Jolla, California
- +3 more
Dec 7, 2022
Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)
Not yet recruiting
- Triple Negative Breast Cancer
- Cryoablation
- Cryoablation combined with PD1 Inhibitor
- (no location specified)
Mar 28, 2023
Patients With Cancer Undergoing Radiation Therapy
Terminated
- Malignant Neoplasm
- cytology specimen collection procedure
- laboratory biomarker analysis
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Aug 15, 2022
Oncology, NSCLC Stage IV, NSCLC, Stage III Trial in Drammen (UV1, Sagramostim, Anti-PD-1/PD-L1 treatment)
Recruiting
- Oncology
- +2 more
- UV1
- +2 more
-
Drammen, Viken, NorwayVestre Viken Health Trust
Aug 15, 2022
Chronic Granulomatous Disease, CGD Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (JSP191)
Recruiting
- Chronic Granulomatous Disease
- CGD
- JSP191
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 5, 2023
Advanced Malignant Solid Tumor, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Trifluridine and Tipiracil Hydrochloride
- Talazoparib Tosylate
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 2, 2022
Blood Flow Restriction, ACL Tear, ACL Injury Trial in Farmington (Blood Flow Restriction using Delfi Personalized Tourniquet
Active, not recruiting
- Blood Flow Restriction
- +2 more
- Blood Flow Restriction using Delfi Personalized Tourniquet System
-
Farmington, ConnecticutConnecticut Children's Sports Physical Therapy
Mar 30, 2022
NSCLC Trial in Guangzhou (Savolitinib, Placebo)
Recruiting
- Non-small Cell Lung Cancer
- Savolitinib
- Placebo
-
Guangzhou, ChinaGuangdong General Hospital
Nov 29, 2021
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial (enoblituzumab, MGA012, MGD013)
Withdrawn
- Head and Neck Cancer
- Squamous Cell Carcinoma of Head and Neck
- enoblituzumab
- +2 more
- (no location specified)
Feb 4, 2022
Stroke Trial in Peshawar (kinesiotaping, motor relearning program)
Recruiting
- Stroke
- kinesiotaping
- motor relearning program
-
Peshawar, PakistanRehman Medical Institute
Dec 9, 2022
Chromosomal Instability in Early Diagnosis of Biliary Tract
Recruiting
- Biliary Tract Carcinoma
- The extracted DNA from bile samples will be analyzed by BileCAD to determine the level of CIN.
-
Taizhou, Zhejiang, ChinaTaizhou Hospital of Zhejiang Province
Apr 25, 2023
Hematologic Malignancies Trial in Hangzhou (RD13-01 cell infusion)
Completed
- Hematologic Malignancies
- RD13-01 cell infusion
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,College of Medicine, Zhejiang Univ
Jan 8, 2022
Spinal Muscular Atrophy Trial in Worldwide
Not yet recruiting
- Spinal Muscular Atrophy
-
Buenos Aires, Caba, Argentina
- +20 more
Jul 24, 2022
Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)
Recruiting
- Bronchial Cancer
-
Strasbourg, FranceService de chirurgie thoracique - CHU de Strasbourg - France
Oct 28, 2022
Peripheral T-Cell Lymphoma Trial in Zhengzhou (Parsaclisib, Chidamide)
Not yet recruiting
- Peripheral T-Cell Lymphoma
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Dec 26, 2021
Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Not Having Achieved Remission, Acute Lymphoblastic
Unknown status
- Acute Lymphoblastic Leukemia, in Relapse
- +2 more
- CD19-CAR-T2 Cells
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Oct 25, 2020